Inflammatory conditions can profoundly alter human neutrophils, a leukocyte subset generally viewed as terminally differentiated and catabolic. In cystic fibrosis (CF) patients, neutrophils recruited to CF airways show active exocytosis and sustained phosphorylation of prosurvival, metabolic pathways. Because the CF airway lumen is also characterized by high levels of free glucose and amino acids, we compared surface expression of Glut1 (glucose) and ASCT2 (neutral amino acids) transporters, as well as that of PiT1 and PiT2 (inorganic phosphate transporters), in blood and airway neutrophils, using specific retroviral envelope-derived ligands. Neither nutrient transporter expression nor glucose uptake was altered on blood neutrophils from CF patients compared with healthy controls. Notably, however, airway neutrophils of CF patients had higher levels of PiT1 and Glut1 and increased glucose uptake compared with their blood counterparts. Based on primary granule exocytosis and scatter profiles, CF airway neutrophils could be divided into two subsets, with one of the subsets characterized by more salient increases in Glut1, ASCT2, PiT1, and PiT2 expression. Moreover, in vitro exocytosis assays of blood neutrophils suggest that surface nutrient transporter expression is not directly associated with primary (or secondary) granule exocytosis. Although expression of nutrient transporters on CF blood or airway neutrophils was not altered by genotype, age, gender, or Pseudomonas aeruginosa infection, oral steroid treatment decreased Glut1 and PiT2 levels in blood neutrophils. Thus, neutrophils recruited from blood into the CF airway lumen display augmented cell surface nutrient transporter expression and glucose uptake, consistent with metabolic adaptation.
Metabolic adaptation of neutrophils in cystic fibrosis airways involves distinct shifts in nutrient transporter expression
Laval, J.; Touhami, J.; Herzenberg, L. A.; Conrad, C.; Taylor, N.; Battini, J. L.; Sitbon*, M.; Tirouvanziam*, R.
2013-06-15 / vol 190 / pages 6043-50
10.4049/jimmunol.1201755 jimmunol.1201755 [pii]
1550-6606 (Electronic) 0022-1767 (Linking)
IGMM team(s) involved in this publication
Rétrovirus, Enveloppes et Marqueurs Métaboliques
NAOMI TAYLOR / VALERIE ZIMMERMANN
Hematopoïèse et Immunothérapie
Humans; Flow Cytometry; Amino Acid Transport System ASC/metabolism; Cystic Fibrosis/*immunology/*metabolism; Glucose Transporter Type 1/metabolism; Membrane Transport Proteins/*metabolism; Neutrophils/*immunology/*metabolism; Sodium-Phosphate Cotransporter Proteins, Type III/metabolism